Skip to main content
Premium Trial:

Request an Annual Quote

Products & Services: Jul 23, 2009


Thermo Fisher Scientific, the parent firm of Dharmacon, has announced the RNAi Discovery Grant Program.

The program will award more than $400,000 worth of the company's RNAi-based reagents through five awards made to researchers who submit research proposals for projects that "have the potential to significantly impact science and medicine."

Details on the awards, as well as information on submitting proposals, can be found here.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.